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The relationship between DNase I-hypersensitive sites (HSs) and transcriptional enhancers of the rat tyrosine
aminotransferase (TAT) gene was examined by comparing HSs in and around the TAT gene with the activity
of the corresponding DNA sequences in transient transfection assays. In this manner, we identified two HSs as
liver-specific enhancers. Of three hepatoma cell lines examined, only one sustained TAT mRNA levels
comparable to those of liver. In this cell line, both enhancers were strongly active, and strong hypersensitivity
in chromatin over the enhancers was evident. The other two hepatoma cell lines had reduced levels of TAT
mRNA and no or altered hypersensitivity over either the enhancers or the promoter. One of these lines carried
a negative regulator of the TAT gene, the tissue specific extinguisher Tse-1. This cell line exhibited all HSs
characteristic of the strongly active gene except at the promoter; however, one enhancer was inactive even
though hypersensitive in chromatin. In a TAT-nonexpressing cell line, inactivity of both enhancers correlated
with absence of the respective HSs. We conclude that although hypersensitivity in chromatin necessarily
accompanies cell-type-specific enhancer activity, the occurrence of cell-type-specific HSs does not imply that the
underlying sequences harbor enhancers active in transient transfection assays.
The association of DNA and protein in the nucleus of
eucaryotic cells is referred to as chromatin. The bulk of
chromatin is nucleosomal; however, short nucleosome-
free regions are detectable by an enhanced rate of cleavage
with DNase I and are termed DNase I-hypersensitive sites
(DNase I HSs). HSs correlate with regions where cis-
regulatory elements lie, and it is believed that the hypersen-
sitivity to nucleases reflects accessibility to regulatory pro-
teins (see references 11 and 25 for reviews). Thus, the
mapping of HSs surrounding a gene offers a means to locate
potential cis-regulatory elements. For example, extensive
analysis of chromatin features in the chicken lysozyme gene
domain in expressing and nonexpressing tissues and cell
lines has elucidated the sequences that control cell-specific
and hormone-responsive expression of this gene (summa-
rized in reference 15).
Recent advances in the understanding of regulated gene
expression in higher eucaryotes have highlighted the fact
that cis-regulatory elements are frequently located at rela-
tively large distances from the promoter. Studies of the
mammalian albumin gene have demonstrated that high-level,
tissue-specific expression is a property of the promoter
region (20, 30, 38). However, appropriate expression of
albumin gene constructs in transgenic mice requires an
element located 10 kilo base pairs (kb) upstream (39).
Similarly, elements located 50 kb 5' to the ,B-globin gene
convey position-independent and copy-number-dependent
expression in transgenic mice (26). In both cases, the up-
stream elements were initially identified as DNase I HSs (13,
39, 48).
To investigate the control of rat tyrosine aminotransferase
(TAT) gene expression, we determined the occurrence of
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HSs in TAT gene chromatin in expressing and nonexpress-
ing cells and designed transfection experiments based on the
location of these sites. The TAT gene is subject to several
levels of gene regulation. It is preferentially expressed in
parenchymal cells of the adult liver (28). Gene activity
increases dramatically a few hours after birth (24). TAT
transcription can be stimulated by glucocorticoid hormones
(23, 42) and by glucagon, which acts via the cyclic AMP
(cAMP) pathway (29, 42; F. Weih et al., submitted for
publication). Both stimuli may be involved in the develop-
mental activation of the gene (40). In addition, analysis of
hepatoma-fibroblast cell hybrids (43) identified a negative
regulator of the TAT gene, termed tissue-specific extin-
guisher 1 (Tse-1; 32). The locus for Tse-J has been mapped to
the distal part of human chromosome 17q (34).
Previously, glucocorticoid-dependent chromatin changes
2.5 kb upstream of the transcription start site (2) led to the
definition of the functional glucocorticoid response element
of the TAT gene (31). Here we identify two HSs that lie
further upstream and function as liver-specific enhancers.
By comparing HSs and the enhancing activities of the
corresponding sequences in different cell lines, we are able
to relate the functional relevance of different chromatin
features to the transcriptional activity of the gene.
MATERIALS AND METHODS
Plasmids. Isolation of rat TAT 5'-flanking sequences to
approximately -18.7 kb from an EMBL3 rat liver library
(44) led to the construction of pTC18.7 and pTC5.9 from
pTC3.0 (pTATCAT in reference 31). These plasmids were
used to construct a 5' deletion series in which the following
restriction sites were used (positions are given in base pairs
upstream of the transcription start site): StuI (approximately
-18000), PvuI (-11116), XbaI (-9232), PvuII (-4289), and
KpnI (-351). Internal deletion constructs were derived from
pTC18.7 by deletion of an XhoI (-3918)-HindIII (-3341)
fragment in pTC18.7A-3.6HS and a PvuI (-11116)-SfiI
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(-8449) fragment in pTC18.7A-11HS. The double-deletion
construct pTC18.7A-11/-3.6HS combines deletion of the
XhoI-HindIII fragment with deletion of a PvuI (-11116)-
ScaI (-9382) fragment. pTC11.1A-3.6HS and pTC9.2A-
3.6HS were cloned by exchange of the BssHII (-4881)-
BamHI (- 1300) fragment between the respective 5' deletion
plasmid and pTC18.7A-3.6HS. pTC-11HS, pTC-5.4HS,
and pTC-3.6HS have the following fragments inserted into
pTCO.35: PvuI (-11116)-ScaI (-9382), ApaI (-6081)-XhoI
(-3918), and XmnI (-3981)-HindIII (-3341), respectively.
For chromatin analysis, single-copy TAT fragments were
cloned into pBluescribe or pBluescript (Stratagene). In ex-
periments depicted in Fig. 2 to 5, the following subclones
were used: pXA600 (XbaI [-9208]-ApaI [-8591]), EB670
(EcoO109 [-1974]-BamHI [-1300]), and SH800 (Saul
[+700]-HindIII [+1500]). Cloning of all plasmids was per-
formed according to standard procedures (1). All plasmids
were grown in an Escherichia coli dam dem strain (GM119),
and purification involved alkaline lysis and two successive
CsCl gradient steps.
Cell culture and transfection. All cells were cultured in
1:1 (vol/vol) Dulbecco modified Eagle medium-Ham F12
medium supplemented with 10% fetal calf serum, 100 U of
penicillin per ml, 100 ,ug of streptomycin per ml, 10 mM
N- 2 - hydroxyethylpiperazine - N' - 2 - ethanesulfonic acid
(HEPES; pH 7.4), and 2 mM glutamine. The medium for
7AD-7 and 7AE-27 cells (34) also contained 800 ,ug of G418
per ml. Transient transfections were performed by lipofec-
tion (12). Cells were plated onto 6-cm-diameter dishes 1 day
before transfection (4 x 106 7AD-7 and 7AE-27, 106 HTC,
and 5 x 105 XC). Both DNA and lipid (30 jig of Lipofectin;
Bethesda Research Laboratories, Inc.) were diluted sepa-
rately in 500 ,ul of HBS buffer (20 mM HEPES [pH 7.4], 150
mM NaCl), mixed, and left for 10 to 15 min at room
temperature. The cells were washed twice with serum-free
medium and then incubated for 3 to 4 h at 37°C with the
lipid-DNA mix. Then 2 ml of serum-free medium was added,
and incubation continued for 12 to 16 h. A further change of
serum-free medium followed, and cells were harvested after
an additional 40 to 48 h. 0.175 pmol of each construct was
made to a total of 2.7 ,ug with carrier DNA (plasmid pUC).
Transfection efficiency was controlled by cotransfection of
an internal reference plasmid (0.04 pmol of pRSVlucAH
[kindly provided by A. Hecht], which is the luciferase gene
under control of the Rous sarcoma virus promoter [9]).
CAT and luciferase assays. Cells were washed twice with
phosphate-buffered saline and harvested in 1 ml of 150 mM
NaCl-40 mM Tris chloride (pH 7.4)-l mM EDTA. Extracts
were prepared by three cycles of freezing and thawing of
cells, 20 min of centrifugation at 4°C, and suspension in 150
,ul of 250 mM Tris chloride (pH 7.8)-i mM EDTA-1 mM
dithiothreitol. Protein concentration was determined by the
method of Bradford (4). Chloramphenicol acetyl transferase
(CAT) assays (19) were performed with 2 mM acetyl coen-
zyme A and 1.25 ,uCi of ["'C] chloramphenicol per ml in 0.25
M Tris (pH 7.8)-5 mM EDTA. Heat treatment (10 min, 60°C)
of the extract was included before the assay to inactivate the
deacetylase activity (7). The assay was quantified by liquid
scintillation counting of the excised reaction products. The
luciferase assay was performed as described elsewhere (9).
HS mapping. Preparation of nuclei from different gluco-
corticoid-induced (10-6 M dexamethasone) tissues and cells,
DNase I digestions, and indirect end-labeling analyses were
performed as described elsewhere (2, 31).
RNA analyses. RNA preparation and Northern (RNA)
analysis were done as described elsewhere (5, 10). The
RNase protection assay was performed as described previ-
ously (31), hybridizing 100 ,ug of total RNA with 10 fmol of
a uniformly labeled SP6 transcript (35). RNA was prepared
from cells transfected as described above and harvested
after 30 h in serum-free medium. Transfection efficiency was
controlled by performing luciferase assays.
RESULTS
Six HSs correlate to high basal level of transcriptional
activity. We performed DNase I HS analysis in liver and
kidney as well as in three hepatoma cell lines, 7AD-7,
7AE-27, and HTC, and the fibrosarcoma line XC (46). The
basal level of TAT gene expression in these tissues and cell
lines was determined by Northern blot analysis (Fig. 1C).
TAT mRNA levels are high in liver and the hepatoma line
7AD-7, low in HTC and 7AE-27 cells, and undetectable in
kidney and the fibrosarcoma line XC. 7AD-7 and 7AE-27 are
microcell hybrids of a hepatoma line derived from H4IIEC3
that retain part of the long arm of human fibroblast chromo-
some 17 (33, 34). Several genetic markers from this chromo-
somal fragment are present in both 7AD-7 and 7AE-27 cells;
however, the Tse-J locus is contained only in 7AE-27 cells.
As previously described (32), the presence of Tse-J resulted
in a dramatic reduction ofTAT mRNA levels (Fig. 1C, lanes
7AD-7 and 7AE-27). This result is a consequence of reduced
transcriptional activity of the gene, as assessed by nuclear
run-on experiments (data not shown). We also compared the
parental cell line H4IIEC3 and its derivative FTO-2B (32)
with 7AD-7 cells and found comparable TAT mRNA levels
and identical chromatin structures (data not shown). The
hepatoma line HTC (47), which originates from a different
tumor do than H4IIEC3-derived cell lines, showed 5- to
10-fold-reduced levels of TAT mRNA compared with liver
and 7AD-7 cells (Fig. 1C).
Chromatin analysis was performed by isolating nuclei
from these tissues and cell lines and treating them with
increasing amounts of DNase I. Fifteen end-labeling strate-
gies were used to cover the entire gene and up to 20 kb of 5'-
and 10 kb of 3'-flanking sequences. The analysis led to the
identification of 11 HSs in addition to those reported previ-
ously (2) (Fig. 1A and B). Each HS is named according to
its approximate position relative to the transcription start
site. These HSs fall into three categories. Two were present
in all tissues and cell lines (-18HS and +12HS). Three
did not correlate to transcriptional activity or inactivity
(-16HS, +4.5HS, and +9HS). The remaining HSs lay
between -11 kb and the start site of transcription and
showed cell type distributions suggestive of a relationship to
the transcriptional activity of the TAT gene. The functional
relevance of the glucocorticoid-dependent HS at -2.5 kb has
been discussed previously (31). All cells in this study were
treated with glucocorticoids before chromatin analysis to
assess whether this site could form. The -2.5HS was the
only glucocorticoid-induced chromatin change observable
throughout the 40 kb examined. We present the most inter-
esting chromatin features in Fig. 2 to 5.
In Fig. 2, HSs visible from -16 to -2 kb are compared in
kidney, liver, 7AD-7, and XC nuclei. Kidney nuclei showed
one prominent HS in this region (-8HS). This HS was not
present in any other case examined. Liver and 7AD-7 nuclei
displayed the same array of HSs in this region except that
liver had an additional HS at -7 kb. XC cells showed only
the -16HS (see also Fig. 3 and 4). Thus, we have identified
four HSs (-11HS, -5.4 HS, -4.5HS, and -3.6HS) in
addition to the previously identified -1.OHS, -2.5HS, and
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FIG. 1. DNase I HSs in the TAT gene. (A) The rat TAT gene from -19 to + 12 kb is depicted. The start site and direction of transcription
are indicated by an arrow at position 0. The various DNase I HSs are indicated by vertical arrows at the top of the figure and are named
according to their approximate positions relative to the transcription start site. Restriction sites relevant for the analyses of Fig. 2 to 8 are
marked. Indirect end-labeling strategies that were used in Fig. 2 to 5 are indicated by arrows below the restriction map; the TAT subclones
used as probes are depicted as black boxes: a, XA600; b, EB670; and c, SH800. (B) Summary of the distribution of the various DNase I HSs
in different expressing and nonexpressing tissues and cell lines. The occurrence and fine structure of each HS are schematically indicated.
(C) Northern analysis of 20 ,ug of total RNA isolated from the indicated tissue or cell line. After electrophoresis, the 1.25% agarose gel was
blotted and hybridized against an SP6 transcript of pSPcTAT3a (41). Hybridization against pSP64cGAPDHa (14) was performed to control for
RNA loaded (data not shown).
promoter HS, which appear only in liver and a TAT-
expressing cell line and are therefore candidates as cis-
regulatory elements.
Differences in chromatin structure of two hepatoma cell
lines that express the TAT gene at low levels. From the basal
level of TAT mRNA (Fig. 1C) and from the chromatin
analysis (Fig. 2), we conclude that 7AD-7 cells best reflect
the status of the TAT gene in liver. Since the levels of TAT
mRNA are considerably lower in the hepatoma lines HTC
and 7AE-27 and absent in XC cells, we examined TAT gene
chromatin in these cells to obtain further indications of the
relationship of the above-observed HSs to transcriptional
activity. These analyses are presented in Fig. 3 to 5, which
show HSs from -7 to +5 kb, from -20 to -10 kb, and from
-3 to +1 kb, respectively.
In HTC nuclei, only four (-11HS, -5.4HS, -2.5HS, and
promoter HS) of the seven HSs present in 7AD-7 nuclei
between -11 kb and the promoter were apparent. Further-
more, the -11HS had a different substructure in HTC than
in 7AD-7 cells (Fig. 4). In contrast, 7AE-27 nuclei displayed
an HS pattern identical to that of the Tse-l-negative line,
7AD-7, except for the promoter HS (Fig. 3 and 5). Analysis
from a nearby restriction site revealed that the promoter HS
in 7AE-27 cells was not completely absent as appears in Fig.
3, but the typical doublet seen in liver, 7AD-7, and HTC cells
was reduced to the proximal cleavage (Fig. 5 and data not
shown). Only HSs at -18 and -16 kb were also present in
the TAT-nonexpressing fibrosarcoma cell line, XC.
Functional analysis of the TAT 5'-flanking sequences by
transient transfection identifies two enhancing elements. Tran-
sient transfection of different TAT-CAT fusion constructs
was undertaken to establish the relationship between the
DNase I HS pattern and transcriptional control regions. A
set of 5' deletion constructs was examined first (Fig. 6A;
constructs are named according to the deletion endpoints).
In 7AD-7 cells, there were small variations in expression of
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FIG. 2. DNase I HS mapping of the TAT 5'-flanking sequences
in liver, kidney, 7AD-7, and XC cells. Nuclei of glucocorticoid-
induced liver, kidney, 7AD-7, and XC cells were incubated with
increasing amounts of DNase I as indicated. After DNA purifica-
tion, 20 jLg of each sample was digested with BamHI, electro-
phoresed on a 0.8% agarose gel, blotted, and indirectly end labeled
to the BamHI site at -1300 in the TAT gene, using a T3 RNA
polymerase transcript of subclone EB670 (Fig. 1A). HSs are indi-
cated by arrows on the right. Artifactual bands are marked by
asterisks (compare with Fig. 3 and 4).
plasmids with deletion endpoints from -18.7 to -4.3 kb.
Further deletion to -3.0 kb, however, led to a >50-fold drop
in CAT activity. The additionally deleted sequences harbor
the -3.6HS. The 5' deletion series was also transfected into
HTC and 7AE-27 cells. Consistent with the reduced endog-
enous TAT mRNA levels in these two cell lines (Fig. 1C),
FIG. 4. DNase I HS mapping of the TAT gene region from -22
to -10 kb. A 20-jig sample of each DNA shown in Fig. 3 was cut
with ApaI, electrophoresed in a 1% agarose gel, blotted, and
indirectly end labeled to the ApaI site at -8591 in the TAT upstream
region, using a T3 RNA polymerase transcript of subclone XA600
(Fig. 1A). Lane C, Protein-free DNA digested with DNase I (50
U/ml). HSs are indicated by arrows on the right.
much lower levels of CAT activity were observed, and
deleting the -3.6HS had no effect (Fig. 6A). However, in
7AE-27 cells, deletion of sequences between -11 and -9 kb
led to a >10-fold drop in activity (compare pTC11.1 with
pTC9.2). A weaker effect (two- to threefold) with the same
constructs was also observed in HTC cells.
To verify the results of the 5' deletion series, plasmids
with internal deletions were transfected to look for loss of
expression compared with the parental plasmid (Fig. 6B).
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FIG. 3. DNase I HS mapping of the TAT gene region from -8 to
+5 kb. Nuclei of glucocorticoid-induced HTC, 7AD-7, 7AE-27, and
XC cells were digested with increasing amounts of DNase I as
indicated. After DNA purification, 20 jig of each sample was cut
with ScaI, electrophoresed in a 0.6% agarose gel, blotted, and
indirectly end labeled to the ScaI site at -9383 in the TAT upstream
region, using a T3 RNA polymerase transcript of subclone XA600
(Fig. 1A). Lane C, Protein-free DNA digested with DNase I (50
U/ml). HSs are indicated by arrows on the right. P, Promoter HS.
FIG. 5. Chromatin differences at the TAT promoter in 7AD-7
and 7AE-27 cells. Nuclei of glucocorticoid-induced 7AD-7 and
7AE-27 cells were digested with increasing amounts of DNase I as
indicated. A 20-jig sample of purified DNA was cut with HindIII,
electrophoresed on a 1.25% agarose gel, blotted, and indirectly end
labeled to the HindIII site at +1500 in the TAT-coding sequences,
using a T7 transcript of subclone SH800 (Fig. 1A). HSs are indicated
by arrows on the right. P, Promoter HS.
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FIG. 6. Transient transfection analyses of the 5'-flanking region of the TAT gene. Arrows indicate the various DNase I HSs in the TAT
5'-flanking sequences as in Fig. 1. (A) A 5' deletion series as depicted was fused to the CAT gene at position +62 of the rat TAT gene. The
5' endpoints of the TAT-CAT fusion constructs (pTC) are given on the left (see Materials and Methods for details). 7AD-7, HTC, and 7AE-27
cells were transfected by lipofection (12). The table on the right presents CAT activities of the respective constructs from a representative
experiment. All constructs were tested in at least three independent experiments in each cell line. The absolute activity is given as picomoles
of acetylated chloramphenicol per minute per milligram of extract protein, corrected for variation in transfection efficiency by the expression
of an internal standard (cotransfected pRSVluc [9]). In addition, expression of the different constructs in each cell line is compared relative
to the activity of pTC18.7, which is set at 100% in that cell line. (B) Series of internal deletions which remove the sequences corresponding
to the -11HS or -3.6HS (see Materials and Methods for details); CAT activities derived from a representative experiment are presented as
for panel A.
Internal deletion of the -3.6HS (pTC18.7A-3.6HS) led to a
dramatic drop of expression in 7AD-7 cells (>50-fold) but
had only a twofold effect in 7AE-27 cells and none in HTC
cells. Internal deletion of sequences encompassing the
-11HS (pTC18.7A-11HS) resulted in sixfold-reduced
expression in 7AE-27 cells but only twofold decreased CAT
activity in 7AD-7 and HTC cells. Deletion of both the
-3.6HS and -11HS led to loss of all activation mediated by
the upstream sequences analyzed (compare pTC18.7A-11/
-3.6HS with pTC18.7 and pTCO.35 in Fig. 6B).
The results with the 5' and internal deletion constructs
showed that there is a critical positive regulatory region 3.6
kb upstream of the transcription start site, which is strongly
active in 7AD-7 cells but not in cell lines HTC and 7AE-27.
Additional stimulatory sequences reside in a region that
coincides with the -11HS, but in 7AD-7 cells this is ob-
scured by the strong activity correlating with the more
proximal -3.6HS. The effect of the distal element could be
clearly documented in 7AD-7 cells if the proximal -3.6HS
was deleted (compare pTC11.1A-3.6HS with pTC9.2A
-3.6HS in Fig. 6B).
Figure 7 shows results of transfecting plasmids that posi-
tion individual DNase I HSs in direct proximity to the TAT
promoter. These constructs are designated pTC-11HS,
pTC-5.4HS, and pTC-3.6HS. Comparison of these plas-
mids in 7AD-7, HTC, 7AE-27, and XC cells conclusively
assigns enhancing activity to the sequences containing the
HSs at -3.6 and -11 kb. The construct containing the
-5.4HS and -4.5HS (pTC-5.4HS), on the other hand,
showed no effect. The -3.6 region exerted its 50-fold stim-
ulation only in 7AD-7 cells, weakly in 7AE-27 cells, and not
at all in the hepatoma line HTC, as was apparent from the
results obtained with the 5' deletion mutants. The -11HS,
when placed near the promoter, enhanced TAT transcription
in 7AD-7 and 7AE-27 cells several hundredfold and 5- to
10-fold in HTC cells. Both constructs failed to stimulate
CAT activity in XC cells, demonstrating cell type specificity
of these two elements. Subsequently, we have been able to
confine the sequences responsible for transcriptional en-
hancement entirely to regions within the HSs, and con-
structs containing these HSs in the reverse orientation
produce the same results (data not shown).
Constructs which similarly position the -18HS, -16HS,
and -7HS in front of the TAT promoter failed to reveal any
role for these regions in transcriptional regulation in hepa-
toma and fibroblast cell lines when tested in transient trans-
-18 -16
DNasel HS 4 4
pTC
18.7
18.0
11.1
92
5.9
43
3.0
0.35
18.7
MOL. CELL. BIOL.
I I I I
--Imi
tt.00 --iEia-
-iEn
%%.O' --Za-
-=AT
TAT CHROMATIN AND ENHANCER FUNCTION 3339
.
10 21
-11 -8 7 -5.4 -3.6 -2.5 -1.0 X
DNaselIS 44 4,4 CAT ACTIVITY
kb -14 -13 -12 -11 -10
I I I
-9 -8 -7 -6 -5 -4 -3 -2 -1
i I I I I I I I I rl
CAT
pHDCAT
FIG. 7. Correlation of two DNase I HSs upstream of the TAT gene with regions that stimulate the TAT promoter. DNA fragments that
encompass individual HSs were cloned in front of the TAT promoter at position -351 base pairs as depicted and introduced into three rat
hepatoma cell lines, 7AD-7, HTC, and 7AE-27, and into the rat fibrosarcoma cell line XC. The table on the right presents absolute CAT
activities as in Fig. 6 as well as values relative to the parental plasmid (pTCO.35) in each cell line (fold). As a positive control, the cell lines
were also transfected with pHDCAT (36), a plasmid that contains the simian virus 40 enhancer driving the thymidine kinase gene promoter.
fections (data not shown). This is also the case with the
hepatocyte-specific HS at -1.0 kb. The presence of this site,
for which in vivo protein binding has been documented (3),
does not influence the activity of CAT fusion constructs
(compare pTCO.35 and 3.0 in Fig. 6A). Internal deletion of
this HS also does not change any property measurable in
transient transfections (data not shown). At present, we
cannot rule out the possibility that some of the above-
mentioned HSs must be integrated to convey regulatory
function. Also, HSs at the extreme upstream positions
(-18HS and -16HS) could mark features of a neighboring
locus of other cell type specificity.
To confirm that the effects measured as CAT activity
reflect correct transcriptional regulation at the TAT pro-
moter, RNase protection experiments were performed on
RNAs isolated from 7AD-7 cells. Maximal activity of the
pTC18.7 construct was lost in two steps (Fig. 8): first, upon
deletion of the -11HS (compare pTC11.1 and pTC9.2), and
second, upon deletion of the -3.6HS (pTC4.3 versus
pTC3.0). The activating potential of the distal element com-
pared with that of the proximal element is documented by
constructs which position the respective sequences in front
of the TAT promoter (pTC-11HS and pTC-3.6HS; com-
pare Fig. 7). In all cases, the correct start site has been used;
furthermore, the results qualitatively reflect the effects seen
in the CAT assays.
DISCUSSION
Chromatin and transcriptional control elements of the TAT
gene. We have analyzed 40 kb of chromatin around the rat
TAT gene in different tissues and cell lines for DNase I HSs.
HSs at the extreme 5'- and 3'-flanking sequences (-18HS
and + 12HS) appear in all analyzed nuclei. Some HSs
(-16HS, +4.5HS, and +9HS) do not correspond to tran-
scriptional activity or inactivity. On the other hand, a
complex array of HSs located between the transcription start
site and 11 kb upstream (-11HS, -5.4HS, -4.5HS,
-3.6HS, -2.5HS, -1.OHS, and promoter HS) is observed
in liver and the TAT-expressing hepatoma line 7AD-7.
Interestingly, only three of these HSs (-5.4HS, -2.5HS,
and promoter HS) are fully established in the hepatoma line
HTC, which expresses 5- to 10-fold less TAT mRNA than do
7AD-7 cells. In contrast, 7AE-27, a cell line which shows
even lower basal TAT mRNA levels (Fig. 1C) because of the
presence of the human Tse-J locus (34), differs from 7AD-7
cells in DNase I HS pattern only in reduced hypersensitivity
at the promoter.
Transient transfection experiments have defined two re-
gions that stimulate TAT transcription, in addition to the
glucocorticoid responsive enhancer at -2.5 kb previously
described (31). These two enhancers lie far upstream of the
promoter and coincide with the -3.6HS and -11HS. Both
elements act in a hepatoma-specific manner; however, the
activity of the -3.6 enhancer is restricted to the H4IIEC3-
derived cell line 7AD-7. It is not active in HTC cells, which
do not show the corresponding HS. The -3.6 enhancer also
contains a cAMP response element of the TAT gene, which
not only mediates cAMP responsiveness but also functions
to raise the basal level of TAT transcription (Weih et al.,
submitted). We conclude that in HTC cells, the lower basal
level of TAT transcription as well as the absence of a
transcriptional response to cAMP alone (22) is in part due to
the inactivity of the enhancer that creates this HS. In 7AE-27
cells the -3.6 enhancer activity is greatly reduced, but the
corresponding HS is as strong as that which lies over the
active enhancer in 7AD-7 cells. A detailed analysis of this
enhancer and the basis of its inactivity in 7AE-27 cells will be
presented elsewhere (M. Boshart, F. Weih, A. Schmidt,
R. E. K. Fournier, and G. Schutz, Cell, in press).
The TAT gene has a second far upstream enhancer
(-11HS) whose activity in CAT assays is obscured by the
strong effect of the more proximal -3.6HS when both
elements are active. Constructs which juxtapose the respec-
tive sequences to the TAT promoter establish that the
upstream enhancer is the stronger of the two (Fig. 7 and 8).
Possibly transient transfection experiments are inadequate
to describe fully the in vivo function of the distal element. In
the a-fetoprotein gene, three enhancers, located 2.5, 5.0, and
6.5 kb upstream, were shown to be functionally equivalent
and nonadditive in transient transfections (16, 17). Trans-
genic mice and chromatin analysis, however, defined varia-
tions between tissues in the utilization of the three enhancers
(18, 27). Redundance of transcriptional enhancers might also
reflect a sequential activation during development. The
dominant control region (DCR) of the P-globin gene cluster
may function to establish the character of this domain, since
pTC
0.35
-3.6HS
-5.4HS
-11HS
7AD-7 HTC 7AE-27 XC
=Wm fold Ini pf oldnmmn.mg en.mg fold mmmg fd inmg fold
0.09 1 0.21 1 0.10 1 0.15 1
4.79 53 0.04 < 1 0.25 2.5 0.07 < 1
0.02 < 1 0.08 < 1 0.05 c1 0.05 < 1
38.61 429 1.05 5 42.4 424 0.13 c 1
6.80 - 52.8 - 11.4 - 112 -
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FIG. 8. The TAT enhancers stimulate transcription at the correct
start sites. 7AD-7 cells were transfected with pTC constructs as
indicated at the top. Total RNA was prepared; 100 ,ug was hybrid-
ized to a uniformly labeled antisense SP6 transcript of subclone
pSpTATCAT (31) and digested with RNase. Protected fragments
were separated on a 6% sequencing gel. The TAT gene displays
microheterogeneity at its start site; correctly initiated transcripts are
indicated by arrows and braces on both panels. Upstream starts are
marked by an asterisk. Lane P, undigested probe; lane C, RNA from
untransfected 7AD-7 cells; lane M, HpaII-digested, end-labeled
pBR322. Fragment sizes in base pairs are indicated on the left. (B)
Shorter exposure of the lower half of the gel to observe transcripts
originating from the endogenous TAT gene, which served as an
internal control.
the HSs that mark the DCR appear before P-globin transcrip-
tion in minilocus reconstructions (49) and the DCR conveys
independence from position effects in transgenic mice (26).
For the TAT gene, the distal element (-11HS) could func-
tion early in development to establish an activated locus in
which regulated gene expression is then conferred by the
other cis-regulatory elements. Preliminary HS observations
made on the TAT gene in fetal livers support this hypothesis.
Although the promoters ofmany other liver genes strongly
stimulate transcriptional activity (6, 8, 16, 17, 20, 30, 37), we
observed that the TAT promoter is relatively weak in the
absence of its upstream elements. Nevertheless, the obser-
vation that the presence of Tse-J alters the promoter-HS
(Fig. 5) may suggest a role for the promoter in transcriptional
control of the TAT gene.
Functional relevance of the different chromatin states of the
TABLE 1. Summary of TAT enhancer activities as analyzed by
transient transfection, the structure of corresponding DNase I
HSs, and TAT mRNA levels in different cell lines
- 11 - 3.6 -2.5a pb basalTAT
mRNA
cell line activity HS activity HS inducibility HS HS levels
C
7AD-7 *.... ** I * *l high
HTC * II _ abs*nt Il low
7AE-27 II. +(- )I * * low
XC - absent - absent * wd absent un-
detectable
a Inducibility of the -2.5 enhancer and HS by glucocorticoids.
b Promoter.
c Data not shown.
TAT gene. By contrasting enhancer activity in transient
transfection assays with the occurrence and structure of the
corresponding HSs in four cell lines (Table 1), a descriptive
understanding of the transcriptionally active TAT gene is
now possible. In the highly differentiated hepatoma cell line
7AD-7, both -11 and -3.6 enhancers are active and display
strong HSs in chromatin. The promoter HS is strong, and
high levels of TAT mRNA are produced. Transcriptional
activity can be stimulated by either glucocorticoids, which
induce the -2.5 enhancer and HS, or cAMP, whose effect is
mediated by a cAMP response element resident in the
-3.6HS (Table 1; Weih et al., submitted).
In another hepatoma cell line, HTC, the -11 enhancer
activity and corresponding HS are weaker than in 7AD-7
cells. The -3.6 enhancer activity and HS are absent. The
reduced activity of these two enhancers correlates to lower
levels of endogenous TAT mRNA. The promoter-HS is
strong, and the transcriptional activity of the gene can be
stimulated by glucocorticoids through the inducible en-
hancer and HS at -2.5 kb.
In the Tse-J-containing cell line 7AE-27, the -11 enhancer
activity and HS are both strong. Although the -3.6 enhancer
is almost completely inactive, its corresponding HS is fully
established. By comparison with HTC cells, it can be seen
that both of these enhancers are more active in 7AE-27 cells,
although TAT mRNA levels are lower (Table 1). This
incongruency suggests that the promoter has functional
relevance, since in 7AE-27 cells, hypersensitivity is altered
only at the promoter. The reduced promoter HS may be a
result of direct action by Tse-1. Alternatively, it may be a
consequence of Tse-l-induced alterations of the -3.6 en-
hancer. The following observation might also indicate a role
of promoter sequences in TAT gene control in 7AE-27 cells.
In transient transfection experiments, the -2.5 enhancer
responds to glucocorticoids. However, transcriptional stim-
ulation of the endogenous gene is impaired, even though the
HS is inducible (32; data not shown). Experiments to estab-
lish whether Tse-1 exerts an effect on the TAT gene in HTC
cells, in which the -3.6HS is not present, would resolve this
issue.
In XC cells, both the -11 and -3.6 enhancers are inactive
and the corresponding HSs are absent. The -2.5HS is not
inducible with glucocorticoids, but the corresponding en-
hancer activity is partially inducible. This finding indicates
the presence of the glucocorticoid receptor in XC cells and
its ability to activate the -2.5 enhancer when the latter is
transfected but not in chromatin.
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Correlation between a DNase I HS and enhancer activity. In
addition to the chromatin-guided definition of two transcrip-
tional enhancers in the rat TAT gene, this study documents
other DNase I HSs which also appear exclusively in express-ing cell lines and liver but so far could not be correlated with
function (-5.4HS, -4.5HS, and l.OHS). After completion of
this report, we became aware of a recent report by Grange et
al. (21). The authors suggest a functional role for the -5.4HS
in steroid hormone response in H4IIEC3 cells. After trans-
fection of similar constructs and induction in the two hepa-
toma cell lines FTO-2B and HTC, we cannot confirm these
observations (data not shown).
For the -1.OHS, in vivo protein-DNA interaction, hypo-
methylation in cells in which the gene is transcribed, and in
vivo topoisomerase I activity have been documented (3, 45).
So far, no function for this DNase I HS has been found.
Furthermore, although we observe a correlation between
enhancer activity and the structure of the -11HS, we also
find, with the -3.6HS, a situation where hypersensitivity
over an enhancer does not correlate to the activity of the
enhancer. These findings lead us to draw the following
unidirectional conclusion. cis elements that regulate cell-
type-specific gene transcription lie within DNase I HSs.
However, the occurrence of a cell-type-specific DNase I HS
does not imply the existence of cis-regulatory elements
active in transient transfection assays.
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